MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
issuance of common stock
$104,495K
Net cash provided by
financing activities
$98,230K
Canceled cashflow
$6,265K
Net increase in
cash, cash...
$94,311K
Canceled cashflow
$3,919K
Share issuance
transaction costs
$6,265K
Share-based compensation
expense
$7,379K
Trade and other
payables
$701K
Trade and other
receivables
-$123K
Amortization of right-of-use
assets
$106K
Accrued employee
benefits
$19K
Depreciation and
amortization
$14K
Net cash used in
operating activities
-$3,776K
Effects of exchange rate
changes on cash, cash...
-$132K
Net cash used in
investing activities
-$11K
Canceled cashflow
$8,342K
Net loss
-$11,837K
Purchase of property and
equipment
$11K
Prepaid and other assets
$195K
Lease liabilities
-$86K
Back
Back
Cash Flow
source: myfinsight.com
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)